Pag. 1 a 4
Program - ICTHIC May 27-29, 2022 Friday, May 27
th2022
8:45 – 09:00 Congress Opening: Anna Falanga, Benjamin Brenner, Alok A. Khorana
9:00 – 11:15 Plenary Session 1: Emerging trends in cancer associated thrombosis Chairs: TBA
1. Frits Mulder (The Netherlands). VTE in cancer in contemporary era
2. Cliona Kirwan (UK). Thrombosis and coagulation in the contemporary management of breast cancer
3. Grigoris Gerotziafas (France). Machine learning for risk stratification of CAT
4. Kristen M. Sanfilippo (USA). Thrombosis and risk stratification in hematological malignancies.
Oral Communications
11:15 – 13:30 Plenary Session 2: Exploring the relationship between hemostasis and cancer: New insights Chairs: TBA
1. Ronit Satchi-Fainaro (Israel). Hemostatic mechanisms in glioblastoma progression 2. Simon Mantha (USA). Cancer mutations and thromboembolic risk
3. Axel Rosell (Sweden). The role of neutrophil extracellular traps in CAT.
4. Nina Iversen (Norway). Molecular mechanisms of TF/TFPI pathway regulation in tumor cells Oral Communications
13:30 – 14:30 Lunch sessions 14:30 – 15:00 Coffee and pastries
15:00 – 17:15 Plenary Session 3: Role of hemostatic biomarkers in CAT and cancer progression Chairs: TBA
1. Jamie Marie O’Sullivan (Ireland). Bi-directional cross talk between coagulation and cancers: current assessment of pre-clinical evidence
Pag. 2 a 4 2. Aurélien Delluc (Canada). PET scan for occult cancer among patients with unprovoked VTE: what
do we know?
3. Laurence Panicot-Dubois (France). The role of platelets in cancer progression
4. M. Marchetti (Italy). Hemostatic system activation in breast cancer: searching for new biomarkers of cancer outcome
Oral Communications
17:15- 17:45 Coffee Break
17:45 – 18:45 DEBATE: Catheter-associated Thrombosis in cancer patients: To prophylaxis or not to prophylaxis?
Chairs: TBA
YES: Marc Carrier (Canada) NO: Cecilia Becattini (Italy)
18.45 – 19.30 Plenary Lecture: 7th Simon Karpatkin Memorial Lecture Chairs: Anna Falanga (Italy); Benjamin Brenner (Israel); Alok A Khorana (USA) Introduction to Lecture: TBA
Joe Palumbo (USA). Haemostatic system, immunity, and Inflammation in Cancer.
19.30 – 20.30 Welcome Reception
Saturday, May 28
th2022
8:30 – 10:45 Plenary session 4: Hemostatic complications and novel anti-cancer therapies Chairs: TBA
1. Keith McCrae (USA). Old is new again: emergence of thromboembolic complications in cancer patients on immunotherapy
2. Florian Moik (Austria). Emerging data linking thrombosis to targeted anti-cancer treatments 3. Tzu-Fei Wang (Canada). Drug-drug interaction: implications for cancer associated VTE treatment 4. Rupert Bauersachs (Germany). Bleeding risk with direct oral anticoagulants in cancer patients Oral Communications
10:45 – 12:30 Poster sessions with coffee and pastries
12:30 – 13:30 SPECIAL LECTURE:
Chairs: TBA
Pag. 3 a 4 Maria Luisa Lavitrano (Italy). Importance of biobanking in cancer and thrombosis research: building new
‘horizons’
13:30 – 14:30 Lunch sessions 14:30 – 15:00 Coffee and pastries
15:00 – 17:15 Plenary Session 5: COVID-19, thrombosis, and cancer Chairs: TBA
1. Nicole Kuderer (USA). Cancer and COVID-19: where are the data?
2. Marcel Levi (UK). COVID-19 associated coagulopathy in cancer 3. Mandy N Lauw (The Netherlands). Thrombosis in acute leukemia
4. JM Connors (USA). Essentials of Vaccine-induced thrombotic thrombocytopenia Oral Communications
17:15– 17:45 Coffee
17:45 – 19:00 ROUND TABLE: Multidisciplinary approach in Cardiovascular Oncology Chairs: TBA
Introduction: A. Khorana (USA). Building a CAT Clinic - Real-World Systems Approaches to Prevention and Treatment
Discussants: B. Brenner (Israel), AJ Kakkar (UK), N. van Es (The Netherlands), I. Elalamy (France), A.J.
Munoz (Spain), M.B. Monreal (Spain).
20.00 Presidential dinner
Sunday, May 29th 2022
8:30 – 10:45 Plenary Session 6: Cardiovascular complications in cancer patients Chairs: TBA
1. Hugo Ten Cate (The Netherlands): Evolving data on cardiovascular complications in cancer 2. Alexandros D. Tselepis (Greece). Cardiotoxic effects of antitumor agents: Pathogenetic
mechanisms.
3. Antonella Tufano (Italy). Optimizing antithrombotic therapy for atrial fibrillation in cancer.
4. Josè J Fuster (Spain). Clonal hematopoiesis and cardiovascular complications in cancer patients Oral Communications
Pag. 4 a 4 11:45- 12:45 Italian Brunch
10:45 – 11:45 Debate: Duration of VTE treatment beyond 6 months: To continue or not to continue?
Chairs: TBA
YES: Agnes Lee (Canada) NO: Marcello Di Nisio (Italy)
12:45 – 15:00 Plenary 7: Prevention and treatment of Cancer-Associated Thromboembolism Chairs: TBA
1. Anna Falanga (Italy). Prevent and Treat VTE in cancer patients: ESMO Guidelines 2. J Zwicker (USA). Survival benefit of warfarin for treatment of CAT
3. Michails Karamouzis (Greece). The impact of thromboprophylaxis on the survival of patients with pancreatic cancer
4. Avi Leader (Israel). Non-Bacterial Thrombotic Endocarditis in cancer patients: diagnosis and management
5. Simon Noble (UK). Risk benefit analysis of anticoagulation in elderly cancer patients Oral Communications
15:00 – 15:10 Concluding Remarks
